Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate

Gene-Jack Wang, Nora Volkow, Timothy Wigal, Scott Kollins, Jeffrey Newcorn, Frank Telang, Jean Logan, Christopher Wong, Joanna Fowler and James Swanson
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 329;
Gene-Jack Wang
1Medical Department, Bldg 490, Upton, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora Volkow
2NIAAA/NIDA, Rockville, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Wigal
3University of California, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Kollins
4Duke University, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Newcorn
5Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Telang
2NIAAA/NIDA, Rockville, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Logan
1Medical Department, Bldg 490, Upton, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Wong
1Medical Department, Bldg 490, Upton, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Fowler
1Medical Department, Bldg 490, Upton, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Swanson
3University of California, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

329

Objectives Stimulant medications (methylphenidate and amphetamine) are the treatments of choice in ADHD and are believed to acutely compensate for a chronic dopamine (DA) deficit in this disorder. However the effects of long-term (ie, one year) stimulant medication on brain DA activity in ADHD have not been evaluated.

Methods To measure dopaminergic responsivity before and after long-term treatment with stimulant medication we assessed dopamine D2 receptor availability (D2R) with placebo (PL) and with intravenous methylphenidate (iv, 0.5 mg/kg) in 18 never-medicated ADHD subjects (31±9 yrs of age) twice, prior to treatment initiation (BL) and after 1 year of treatment with oral MP (FU). D2R availability (Binding PotentialND) was computed from manually drawn ROIs using Logan plots. Dopaminergic responsivity was assessed as changes in D2R availability between iv MP and PL at BL and FU.

Results Prior to treatment, D2R availability in caudate-CA was: 3.0±0.4, in putamen-PU: 3.6±0.3 and in ventral striatum-VS: 3.1±0.5. Long-term MP treatment decreased D2R availability in CA (-10±14%, p < 0.005) and PU (-7±10%, p < 0.006). Dopaminergic responsivity corresponded in CA to -12±11%, p<0.0001; in PU to -26±8%, p<2x10-10; and in VS to -18±15%, p<0.0001 for the evaluation performed at BL. Long-term MP treatment significantly attenuated the dopaminergic responsivity to iv MP in PU (-18±9%) when compared with BL (p<0.005).

Conclusions This study reveals that long-term MP treatment of naïve, adults with ADHD reduced striatal D2R availability and attenuated the responses to iv MP. The attenuated DA responses to iv MP after long-term treatment could underlie the decreases in MP’s efficacy (tolerance). Further study will assess whether the attenuated dopaminergic responsivity is associated therapeutic efficacy.

Research Support NIMH/NIAAA/GCRC & DOE (infrastructure support)

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate
Gene-Jack Wang, Nora Volkow, Timothy Wigal, Scott Kollins, Jeffrey Newcorn, Frank Telang, Jean Logan, Christopher Wong, Joanna Fowler, James Swanson
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 329;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate
Gene-Jack Wang, Nora Volkow, Timothy Wigal, Scott Kollins, Jeffrey Newcorn, Frank Telang, Jean Logan, Christopher Wong, Joanna Fowler, James Swanson
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 329;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Subcortical D3/D2 receptor binding in cocaine dependent humans
  • Release of striatal dopamine during response inhibition
  • Decreased striatal dopamine transporters densities in methamphetamine users after a short-term abstinence: A Tc-99m-TRODAT-1 SPECT study
Show more Neurosciences: Psychiatry

Psychiatry: Imaging in Psychiatric Disorders II

  • Metabolic PET imaging study of bilateral capsulotomy in refractory obsessive compulsive disorder
  • Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
  • Distribution of methamphetamine in the human body: Ethnic effects
Show more Psychiatry: Imaging in Psychiatric Disorders II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire